Fluctuating parkinsonism: A pilot study of single afternoon dose of levodopa methyl ester

Fabrizio Stocchi, Luca Barbato, Lucia Bramante, Giampietro Nordera, Laura Vacca, Stefano Ruggieri

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Thirty-four patients with idiopathic fluctuating Parkinson's disease and early afternoon 'delayed on' or severely resistant 'off' periods, in spite of long-term antiparkinsonian therapy, were studied. The first afternoon levodopa administration was substituted with an equimolar dosage of the liquid formulation levodopa methyl ester (LDME). The major end-points for efficacy were latency to 'on' and duration of 'on' periods. The patients were divided into five subgroups according to their baseline treatment and they were evaluated monthly for 6 months using the Unified Parkinson's Disease Rating Scale. The patients completed weekly self-evaluation using an 'on-off' chart. LDME was well tolerated by all the patients. A statistically significant reduction in latency to 'on' was observed in all patients. The clinical effect of LDME remained stable during the treatment period (repeat measures ANOVA). The more rapid clinical effect of LDME and its stable and predictable antiparkinsonian activity represents a new and useful approach for treating patients with complicated Parkinson's disease.

Original languageEnglish
Pages (from-to)377-380
Number of pages4
JournalJournal of Neurology
Volume243
Issue number5
DOIs
Publication statusPublished - 1996

Fingerprint

Parkinsonian Disorders
Antiparkinson Agents
Parkinson Disease
Diagnostic Self Evaluation
Levodopa
levodopa methyl ester
Analysis of Variance
Therapeutics

Keywords

  • Levodopa
  • Levodopa methyl ester
  • Motor fluctuations
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Fluctuating parkinsonism : A pilot study of single afternoon dose of levodopa methyl ester. / Stocchi, Fabrizio; Barbato, Luca; Bramante, Lucia; Nordera, Giampietro; Vacca, Laura; Ruggieri, Stefano.

In: Journal of Neurology, Vol. 243, No. 5, 1996, p. 377-380.

Research output: Contribution to journalArticle

Stocchi, Fabrizio ; Barbato, Luca ; Bramante, Lucia ; Nordera, Giampietro ; Vacca, Laura ; Ruggieri, Stefano. / Fluctuating parkinsonism : A pilot study of single afternoon dose of levodopa methyl ester. In: Journal of Neurology. 1996 ; Vol. 243, No. 5. pp. 377-380.
@article{898a768985a947d79c4fea9557f7c161,
title = "Fluctuating parkinsonism: A pilot study of single afternoon dose of levodopa methyl ester",
abstract = "Thirty-four patients with idiopathic fluctuating Parkinson's disease and early afternoon 'delayed on' or severely resistant 'off' periods, in spite of long-term antiparkinsonian therapy, were studied. The first afternoon levodopa administration was substituted with an equimolar dosage of the liquid formulation levodopa methyl ester (LDME). The major end-points for efficacy were latency to 'on' and duration of 'on' periods. The patients were divided into five subgroups according to their baseline treatment and they were evaluated monthly for 6 months using the Unified Parkinson's Disease Rating Scale. The patients completed weekly self-evaluation using an 'on-off' chart. LDME was well tolerated by all the patients. A statistically significant reduction in latency to 'on' was observed in all patients. The clinical effect of LDME remained stable during the treatment period (repeat measures ANOVA). The more rapid clinical effect of LDME and its stable and predictable antiparkinsonian activity represents a new and useful approach for treating patients with complicated Parkinson's disease.",
keywords = "Levodopa, Levodopa methyl ester, Motor fluctuations, Parkinson's disease",
author = "Fabrizio Stocchi and Luca Barbato and Lucia Bramante and Giampietro Nordera and Laura Vacca and Stefano Ruggieri",
year = "1996",
doi = "10.1007/BF00868995",
language = "English",
volume = "243",
pages = "377--380",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "5",

}

TY - JOUR

T1 - Fluctuating parkinsonism

T2 - A pilot study of single afternoon dose of levodopa methyl ester

AU - Stocchi, Fabrizio

AU - Barbato, Luca

AU - Bramante, Lucia

AU - Nordera, Giampietro

AU - Vacca, Laura

AU - Ruggieri, Stefano

PY - 1996

Y1 - 1996

N2 - Thirty-four patients with idiopathic fluctuating Parkinson's disease and early afternoon 'delayed on' or severely resistant 'off' periods, in spite of long-term antiparkinsonian therapy, were studied. The first afternoon levodopa administration was substituted with an equimolar dosage of the liquid formulation levodopa methyl ester (LDME). The major end-points for efficacy were latency to 'on' and duration of 'on' periods. The patients were divided into five subgroups according to their baseline treatment and they were evaluated monthly for 6 months using the Unified Parkinson's Disease Rating Scale. The patients completed weekly self-evaluation using an 'on-off' chart. LDME was well tolerated by all the patients. A statistically significant reduction in latency to 'on' was observed in all patients. The clinical effect of LDME remained stable during the treatment period (repeat measures ANOVA). The more rapid clinical effect of LDME and its stable and predictable antiparkinsonian activity represents a new and useful approach for treating patients with complicated Parkinson's disease.

AB - Thirty-four patients with idiopathic fluctuating Parkinson's disease and early afternoon 'delayed on' or severely resistant 'off' periods, in spite of long-term antiparkinsonian therapy, were studied. The first afternoon levodopa administration was substituted with an equimolar dosage of the liquid formulation levodopa methyl ester (LDME). The major end-points for efficacy were latency to 'on' and duration of 'on' periods. The patients were divided into five subgroups according to their baseline treatment and they were evaluated monthly for 6 months using the Unified Parkinson's Disease Rating Scale. The patients completed weekly self-evaluation using an 'on-off' chart. LDME was well tolerated by all the patients. A statistically significant reduction in latency to 'on' was observed in all patients. The clinical effect of LDME remained stable during the treatment period (repeat measures ANOVA). The more rapid clinical effect of LDME and its stable and predictable antiparkinsonian activity represents a new and useful approach for treating patients with complicated Parkinson's disease.

KW - Levodopa

KW - Levodopa methyl ester

KW - Motor fluctuations

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=0029882818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029882818&partnerID=8YFLogxK

U2 - 10.1007/BF00868995

DO - 10.1007/BF00868995

M3 - Article

C2 - 8741076

AN - SCOPUS:0029882818

VL - 243

SP - 377

EP - 380

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 5

ER -